Particula | $5,500,000 | (May 1, 2025)
Stimuler | $3,750,000 | (May 1, 2025)
SpriveApp | $7,300,000 | (May 1, 2025)
Certified by Founder
Lodge
Variantyx
start up
United States
- Framingham, Massachusetts
- 20/10/2023
- Unknown
- Undisclosed Amount
Variantyx is a technology-driven precision medicine company providing state-of-the-art diagnostic solutions for the rare genetic disorders and reproductive genetics markets, and treatment optimization in oncology.
Our unique, comprehensive testing platform uses whole genome sequencing to identify all major genetic changes from a single sample. The results empower patients and providers with information that can rapidly end the challenging diagnostic search, optimize treatment, and improve quality of life.
We are a diverse, multinational company that embodies professionalism, transparency, tenacity, and respect. See more with us: www.variantyx.com/.
- Industry Biotechnology Research
- Website https://www.variantyx.com/
- LinkedIn https://www.linkedin.com/company/variantyx/about/
Manifest | $15,000,000 | (May 1, 2025)
Spark Biomedical Inc | $15,000,000 | (May 1, 2025)
Queens Carbon | $10,000,000 | (May 1, 2025)
Noma Therapy | $4,250,000 | (May 1, 2025)
Persona | $200,000,000 | (May 1, 2025)
Nuvo | $45,000,000 | (May 1, 2025)
Pallie | $2,000,000 | (May 1, 2025)
Faye(US) | $2,500,000 | (May 1, 2025)
Structify | $4,100,000 | (May 1, 2025)